Emmaus Life Sciences Announces Engagement of Partner International to Lead Out-Licensing of Endari® for Diverticulosis Jul 16, 2020 8:00am EDT
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Israeli Ministry of Health Jun 29, 2020 8:00am EDT
National Institutes of Health Announces Intention with Respect to Grant of Exclusive Patent License to Emmaus Life Sciences Jun 25, 2020 8:00am EDT
Emmaus Life Sciences Announces SFDA (Saudi Food & Drug Authority) Accepts Endari® Priority Review Request Apr 16, 2020 8:00am EDT
Emmaus Life Sciences Provides Update in Response to the Coronavirus (COVID-19) Pandemic Mar 24, 2020 8:00am EDT
Emmaus Life Sciences Announces Equity Purchase Agreement for up to $25 Million with Lincoln Park Capital Mar 03, 2020 8:00am EST
Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended December 31, 2019 Feb 05, 2020 8:00am EST
